ER-100 epigenetic therapy
2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| ER-100 epigenetic therapy for glaucoma, open-angle | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ER-100 epigenetic therapy for retinal diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |